Diagnosis of Alzheimer Disease Using Plasma B...

In part two of this series, Dr. Andy Southerland talks with Dr. Dan Ackerman about a few rapid‑fire concepts from the 2026 guidelines, focusing on what is new and how emerging data may shape patient care. Disclosures can be found at Neurology.org. 

In part one of this series, Dr. Andy Southerland talks with Dr. Dan Ackerman about the latest guidelines for managing acute ischemic stroke, emphasizing thrombolytic therapy, imaging techniques, and decision-making regarding treatment in extended time windows. Disclosures can be ...  Show more

Dr. Rae Bacharach discusses the Neurology Today article, "Individuals Can Now Request a Blood Test for Alzheimer disease - Why Some Dementia Experts Are Wary". Show references: https://journals.lww.com/neurotodayonline/fulltext/2023/10190/individuals_can_now_request_a_blood_test_ ...  Show more

Dale E. Bredesen

Dale E. Bredesen, M.D., is a professor of neurology at the Easton Laboratories for Neurodegenerative Disease Research at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA).

Dr. Bredesen's labo ...

Hemodialysis catheter-related bloodstream infection (CRBSI) is an ongoing challenge. This podcast features a discussion between healthcare professionals and patient discussing methods aimed at reducing CRBSI risk. The panelists will also provide an update on innovations in the ar ...  Show more

In this intimate finale of a two-part special, Dr. Sanjay Gupta decides to find out his own risk of Alzheimer’s disease. As he confronts his own genetic markers and lifestyle factors, Sanjay breaks down the science behind Alzheimer’s risk and explores what steps might slow down t ...  Show more